2017
DOI: 10.1186/s12859-017-1562-7
|View full text |Cite
|
Sign up to set email alerts
|

Machine learning classifier for identification of damaging missense mutations exclusive to human mitochondrial DNA-encoded polypeptides

Abstract: BackgroundSeveral methods have been developed to predict the pathogenicity of missense mutations but none has been specifically designed for classification of variants in mtDNA-encoded polypeptides. Moreover, there is not available curated dataset of neutral and damaging mtDNA missense variants to test the accuracy of predictors. Because mtDNA sequencing of patients suffering mitochondrial diseases is revealing many missense mutations, it is needed to prioritize candidate substitutions for further confirmation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 30 publications
(22 citation statements)
references
References 47 publications
0
21
0
1
Order By: Relevance
“…As a final test of the model that negative selection acts against deleterious mtDNA variants, we used the MutPred algorithm [36] to compare the pathogenicity of nonsynonymous mutations found in mutator flies to a distribution of MutPred scores created from Monte Carlo simulations of random mutagenesis. The MutPred algorithm uses the structural and functional properties of a protein to predict the functional consequence of a nonsynonymous amino acid substitution, and previous work has established the validity of the MutPred algorithm to predict the consequences of mtDNA mutations [3739]. MutPred assigns scores ranging from 0 to 1 to quantify the pathogenicity of a particular variant, with higher scores indicating a greater likelihood of pathogenicity.…”
Section: Resultsmentioning
confidence: 99%
“…As a final test of the model that negative selection acts against deleterious mtDNA variants, we used the MutPred algorithm [36] to compare the pathogenicity of nonsynonymous mutations found in mutator flies to a distribution of MutPred scores created from Monte Carlo simulations of random mutagenesis. The MutPred algorithm uses the structural and functional properties of a protein to predict the functional consequence of a nonsynonymous amino acid substitution, and previous work has established the validity of the MutPred algorithm to predict the consequences of mtDNA mutations [3739]. MutPred assigns scores ranging from 0 to 1 to quantify the pathogenicity of a particular variant, with higher scores indicating a greater likelihood of pathogenicity.…”
Section: Resultsmentioning
confidence: 99%
“…This proline is conserved in 94.7% of 4,988 eukaryotic (from protists to mammals) p.MT-CYB sequences (Martin-Navarro et al, 2017 ). Pathogenicity predictors, such as MutPred (Pereira et al, 2011 ), PolyPhen-2 and Mitoclass.1 (Martin-Navarro et al, 2017 ), consider this amino acid substitution as a pathogenic mutation. The m.13094T>C mutation has not been reported in these 37,545 human sequences.…”
Section: Resultsmentioning
confidence: 99%
“…This m.13094T>C transition provokes a valine to alanine change in p.MT-ND5 position 253 (Figure 2D ). The valine is conserved in 99.7% of 5,159 eukaryotic p.MT-ND5 sequences (Martin-Navarro et al, 2017 ). This Val253 is located in the p.MT-ND5 transmembrane helix 8 (TMH8), following a serine pair (Ser249 and Ser250) that distorts TMH8 (Zhu et al, 2016 ), and a key His248 sit on a flexible loop of the discontinuous TMH8.…”
Section: Resultsmentioning
confidence: 99%
“…For instance, more than 70% of the confirmed pathogenic mutations were predicted to be benign with SIFT, whereas about 15% of the pathogenic variants were not predicted as such by Polyphen2, highlighting that the tools developed for nDNA are barely suitable for mtDNA. Conversely, recent tools developed for mtDNA using machine learning based approaches (Table 1D) show better performances (Figure 2), as MToolBox (Calabrese et al, 2014), the meta-predictor APOGEE (Castellana et al, 2017), or Mitoclass.1 (Martin-Navarro et al, 2017), confirming the need to pursue the development of tools dedicated to mitochondrial genetics.…”
Section: Mtdna Variant Annotationmentioning
confidence: 93%